St. Jude Medical, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 110   

Articles published

STJ 79.42 +0.06 (0.08%)
price chart
Hired experts back claims St. Jude heart devices can be hacked
Short-selling firm Muddy Waters said in a legal filing on Monday that outside experts it hired validated its claims that St. Jude Medical Inc cardiac implants are vulnerable to potentially life-threatening cyber attacks. U.S. regulators responded by ...
Hired experts support claims St. Jude heart devices can be hacked  Reuters India
Muddy Waters Fights St. Jude Over Pacemaker Reports  Bloomberg
St. Jude Medical Announces Data to be Presented as Late-Breaking Clinical ...
St. Jude Medical will have new data featured during late-breaking clinical trial presentations at the upcoming 2016 Transcatheter Cardiovascular Therapeutics symposium.
Short seller Muddy Waters renews claims of St. Jude Medical cyber vulnerabilities
Short seller Muddy Waters Capital, which holds a short position in St. Jude Medical Inc., claimed Wednesday for the second time that the medical device maker's implantable cardiac devices are vulnerable to cyberattack.
St. Jude Medical Forms Cybersecurity Advisory Group  Wall Street Journal
St. Jude Medical Plans Cybersecurity Advisory Panel  Dark Reading
St. Jude Medical Warns of Battery Problems With Heart Products
St. Jude, based in St. Paul, Minn., is in the process of being acquired by Abbott Laboratories ABT -0.59 % in a cash-and-stock deal initially valued at $25 billion.
Battery Problems in St. Jude Medical Defibrillators  WebMD
Two deaths spark recall of St. Jude heart devices  Reuters
St. Jude Medical Inc. (NYSE:STJ) Analyst Estimates And Rating
St. Jude Medical Inc. (NYSE:STJ) stock is currently trading at about $79.36 and lots of rating firms seem to have a target price set on the stock.
Analysts Offer Predictions for St. Jude Medical Inc.'s Q1 2017 Earnings ...  The Cerbat Gem
Large Cap Key Stocks of the Day: St. Jude Medical Inc. (NYSE:STJ)  The News Journal
St Jude Medical gets approval for chronic pain treatment
St Jude Medical Inc (NYSE:STJ) has received US approval of BurstDR stimulation, a treatment for people with chronic spinal chord (SCS) pain.
St. Jude Medical Announces FDA Approval of BurstDR Stimulation, a New ...  Business Wire (press release)
what are Analysts report about: St. Jude Medical Inc. (NYSE:STJ)  News Oracle
St. Jude Medical, FDA and Top Pediatric Cardiology Experts Announce New ...
ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the launch of the ADO II AS (AMPLATZER™ Duct Occluder II Additional Sizes) pediatric clinical trial.
St. Jude Medical, Inc. Heart Device Recall
St. Jude Medical, Inc. is a global company that designs and manufactures health management solutions, including heart devices.
Earnings Reaction History: St. Jude Medical, Inc., 44.4% Follow-Through ...
St. Jude Medical, Inc. ( STJ ) is due to issue its quarterly earnings report in the upcoming extended-hours session.
St. Jude Medical, Inc. (NYSE:STJ) Files An 8-K
Commenting on the company's financial results, St. Jude Medical President and Chief Executive Officer Michael T. Rousseau said, “Third quarter results continue to confirm that our innovation based growth strategy is on track.
analysts Recommendations: St. Jude Medical Inc. (NYSE:STJ)  News Oracle
Stock on the Move: St. Jude Medical, Inc. (NYSE:STJ)  Post Registrar